Ed Dowd On Pfizer Increasing Their Revenue to $90B After Covid-19 | Ep. 244 | Part 1
PBD Podcast
00:00
Intro
This chapter features a discussion on personal victories and aspirations, before delving into a conversation with a finance expert who critiques mainstream views on vaccine safety. The hosts explore the implications of COVID-19, including effects on finance and upcoming elections, while emphasizing the need for professional healthcare advice.
Transcript
Play full episode
